British drugmaker GSK said on Monday that it would pay up to $1.15 billion to buy Boston-based biopharmaceutical firm IDRx, which is developing a treatment for a rare type of tumour. IDRx, a privately held biotechnology...
TikTok’s US future in limbo: Billionaire Frank McCourt’s Project Liberty proposes acquisition–Will ByteDance say ‘yes’?
TikTok is facing a potential ban in the United States due to national security concerns. Alarms have raised alarms over the app’s data privacy practices, fearing that user data collected by TikTok could be...
Bain Capital raises bid for Australia’s Insignia to $1.8 bln, matches CC Capital
Shares of Australia’s Insignia Financial hit a more than three-year high on Monday as a bidding war escalated, with private equity firm Bain Capital raising its offer to A$2.87 billion ($1.76 billion), in line...
J&J explores bid for Intra-Cellular Therapies, Bloomberg News reports
Drug maker Johnson & Johnson is exploring a bid to acquire Intra-Cellular Therapies, a biopharmaceutical company, Bloomberg News reported on Sunday, citing people familiar with the matter. Intra-Cellular has a...
Ownership Matters in favour of Chemist Warehouse-Sigma Healthcare $5.8 bln deal
Proxy advisory firm Ownership Matters said on Monday it recommends that shareholders of Sigma Healthcare vote in favour of Chemist Warehouse’s reverse takeover of the pharmaceutical company, citing significant...
Prada has been working with Citi on possible bid for Versace, source says
Italy’s Prada, is among the potential suitors looking at fashion group Versace, which has been put up for sale by its parent Capri Holdings, and has been working with Citi to evaluate any bid, a person with...
Constellation Energy to buy Calpine in blockbuster $16.4 billion US power deal
U.S. nuclear power provider Constellation Energy on Friday agreed to buy privately held natural gas and geothermal company Calpine Corp for $16.4 billion, one of the biggest acquisitions in U.S. power industry history...
Blackstone mulls $4 billion-plus sale of Liftoff, sources say
Buyout firm Blackstone is weighing strategic options, including a sale, for Liftoff that could value the mobile app marketing provider at more than $4 billion, including debt, two people familiar with the matter said on...
Asset management firm DBAY to buy UK’s Alliance Pharma in $430 million deal
Britain’s Alliance Pharma said on Friday it has agreed to be acquired by asset management firm DBAY Advisors in an all-cash deal valuing the healthcare group at 349.7 million pounds ($429.6 million). The 62.5...
Biogen proposes to buy remaining stake in Sage in $442 million deal
Drugmaker Biogen will buy all outstanding shares of Sage Therapeutics that it does not already own for $7.22 apiece, a filing showed on Friday, sending the latter’s stock up 34% in extended trade. As per the...
Vingroup’s main foreign investor SK Group to sell part of its stake
South Korean conglomerate SK Group plans to sell about a fifth of its holding in Vietnam’s Vingroup starting from next week, a Vingroup filing showed on Friday. With a 6.05% stake, SK’s group financial...
EU approves Synopsys’ $35 billion Ansys deal under conditions
The European Commission on Friday said it had approved the takeover by chip design software maker Synopsys of software company Ansys, with conditions to the $35 billion cash-and-stock deal announced in January last year...
